Hana Pharm Co., Ltd. (293480.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.8x

Market Cap

KRW 149.65B

MomentumView details →

1D Return

−1.17%

YTD Return

−24.06%

RSI (14)

48.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.8x

Market Cap

KRW 149.65B

RSI (14)

48.1

MomentumView details →

1D Return

−1.17%

YTD Return

−24.06%

ProfitabilityView details →

Gross Margin

61.46%

Net Margin

7.06%

EBITDA Margin

16.81%

ROE (TTM)

5.26%

ROA (TTM)

3.91%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+7.46%

EPS YoY

−14.71%

FCF YoY

—

Revenue CAGR 3Y

+4.34%

EPS CAGR 3Y

−28.81%

EBITDA YoY

−34.52%

EarningsView details →

EPS (Actual)

KRW 476.78

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

−2.55%

Capital & dividendView details →

Debt/Equity

0.21x

Current Ratio

1.96x

Quick Ratio

0.98x

Div Yield

3.09%

Div Rate

KRW 260.00

Div Growth 1Y

−74.51%

Financials snapshotView financials →

Revenue (TTM)

247.31B

Net Income (TTM)

17.46B

Op. CF (TTM)

16.43B

Latest newsMore news →

No recent news for 293480.KS.

Similar companies

Dongwha Pharm.Co.,Ltd000020.KS Daihan Pharmaceutical Co.,Ltd.023910.KQ BNC Korea Co., Ltd.256840.KQ HANDOK Inc.002390.KS Daewon Pharmaceutical Co., Ltd.003220.KS Kyongbo Pharmaceutical Co., Ltd214390.KS Find similar companies →

Latest newsMore news →

No recent news for 293480.KS.